Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NetScientific plc (NSCI) Ordinary GBP5

Sell:5.50p Buy:5.75p 0 Change: 0.13p (2.17%)
Market closed Prices as at close on 6 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:5.75p
Change: 0.13p (2.17%)
Market closed Prices as at close on 6 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:5.75p
Change: 0.13p (2.17%)
Market closed Prices as at close on 6 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring.

Contact details

Address:
PO Box 76075
LONDON
EC3P 3DX
United Kingdom
Telephone:
+44 (020) 35141800
Website:
netscientific.net/

Important dates

Future events
There are no future events available.
Past events
AGM 24 June 2020 24/06/20
Quarterly results 13 May 2020 13/05/20
Final results 27 April 2020 27/04/20
Interim results 19 September 2019 19/09/19

General stock information

EPIC:
NSCI
ISIN:
GB00B9F4MT28
Market cap:
£4.42 million
Shares in issue:
78.56 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • John Clarkson
    Chairman of the Board
  • Ilian Iliev
    Interim Chief Executive Officer, Executive Director
  • Stephen Crowe
    Interim Chief Financial Officer, Company Secretary
  • Lawrence Cohen
    Chief Executive Officer of Glycotest Inc.
  • Bob Englert
    Chief Executive Officer of Vortex Biosciences

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.